| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/28/2006 | US7019125 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2006 | US7019118 Antiinflammatory agents; rheumatic disease |
| 03/28/2006 | US7018839 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 03/28/2006 | US7018835 Cap independent translation enhancer linked with genetic sequence; expressed immunogen in eukaryote cell; antisense agents, vaccines for anthrax, tuberculosis, genetic vaccines; semliki forest virus immunogen, bacterial vaccine vector |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/28/2006 | US7018640 Vaccinating a domesticated bird against coccidiosis comprising administering in ovo, during the final quarter of incubation, an effective immunizing dose of live Eimeria sporozoites or merozoites, or a mixture |
| 03/28/2006 | US7018639 polypeptide and optionally carrier and/or adjuvants having haemolysin activity used for inoculation against gramnegative bacteria; immunology |
| 03/28/2006 | US7018638 Mycoplasma hyopneumoniae bacterin vaccine |
| 03/28/2006 | US7018637 Vaccines; immunology carrier containing epitope binding tocarbohydrates |
| 03/28/2006 | US7018636 Vaccine against Gram-negative bacterial infections |
| 03/28/2006 | US7018634 Surface proteins of Leptospira |
| 03/28/2006 | US7018633 Selective destruction of cells infected with human immunodeficiency virus |
| 03/28/2006 | US7018632 Isolation of tumor cells; incubation |
| 03/28/2006 | US7018631 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 03/28/2006 | US7018616 detection of serum antibodies to tuberculosis using fluorescent dyes conjugated to antigens, then evaluation using analyzing apparatus; biossays |
| 03/28/2006 | US7018615 Administering library then collecting and analyzing sample of biological target material |
| 03/28/2006 | CA2415750C Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 03/28/2006 | CA2372960C Hiv immunogenic compositions and methods |
| 03/28/2006 | CA2106719C Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/23/2006 | WO2006031976A2 Compositions and methods for treating stat-6 associated diseases or conditions |
| 03/23/2006 | WO2006031825A2 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof |
| 03/23/2006 | WO2006031795A2 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/23/2006 | WO2006031703A1 Cytokine-expressing cellular vaccines for treatment of prostate cancer |
| 03/23/2006 | WO2006031653A2 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates |
| 03/23/2006 | WO2006031377A2 A system and method related to enhancing an immune system |
| 03/23/2006 | WO2006031374A1 Intradiscal production of autologous interleukin receptor antagonist |
| 03/23/2006 | WO2006031363A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/23/2006 | WO2006031291A2 A novel class of therapeutic protein based molecules |
| 03/23/2006 | WO2006030956A1 NOVEL USE OF PrPP AND RECEPTOR THEREOF |
| 03/23/2006 | WO2006030947A1 Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 03/23/2006 | WO2006030941A1 Simultaneous use of sulfonamide-containing compound and angiogenesis inhibitor |
| 03/23/2006 | WO2006030802A1 Method of screening baff suppressor or inhibitor |
| 03/23/2006 | WO2006030431A2 Biocompatible drug delivery apparatus and methods |
| 03/23/2006 | WO2006030318A2 PROTECTIVE ANTI-GLUCAN ANTIBODIES WITH PREFERENCE FOR β-1,3-GLUCANS |
| 03/23/2006 | WO2006029891A2 Change of the load state of mhc molecules |
| 03/23/2006 | WO2006029887A2 Vaccines comprising plasmodium antigens |
| 03/23/2006 | WO2006029685A1 Barn dust extract providing protection from allergies |
| 03/23/2006 | WO2006029632A2 Chimeric phage-derived particles, methods for their production and use |
| 03/23/2006 | WO2006029578A1 Interleukin-15 antagonist peptide |
| 03/23/2006 | WO2006029459A1 Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof |
| 03/23/2006 | WO2006010634A8 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 03/23/2006 | WO2005117956A3 Neisserial vaccines |
| 03/23/2006 | WO2005105141A3 Combined meningococcal conjugates with common carrier protein |
| 03/23/2006 | WO2005102938A3 Antibodies specific for bcr-abl fusion protein and uses thereof |
| 03/23/2006 | WO2005102384A3 Immunising against meningococcal serogroup y using proteins |
| 03/23/2006 | WO2005099774A3 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 03/23/2006 | WO2005095975A3 Anti-fungal target genes |
| 03/23/2006 | WO2005094785A3 Compositions capable of facilitating penetration across a biological barrier |
| 03/23/2006 | WO2005093426A3 Diagnostics and therapeutics for diseases associated with retinoic acid receptor alpha (rara) |
| 03/23/2006 | WO2005058967A3 Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof |
| 03/23/2006 | WO2005058006A3 Methods and compositions comprising bacteriophage nanoparticles |
| 03/23/2006 | WO2005049794A3 Methods of characterizing infectious bursal disease virus |
| 03/23/2006 | WO2005047459A3 Sars nucleic acids, proteins, antibodies, and uses thereof |
| 03/23/2006 | WO2005042006A3 Use of ephrins and related molecules to regulate cellular proliferation |
| 03/23/2006 | WO2005032583A3 Liquid vaccines for multiple meningococcal serogroups |
| 03/23/2006 | WO2005013802A3 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 03/23/2006 | WO2005003325A3 Inhibition of viral pathogenesis |
| 03/23/2006 | WO2004111087A3 Chemokin-binding protein thap1, methods and use thereof |
| 03/23/2006 | WO2004110349A3 Sars t cell epitopes and methods for identifying same |
| 03/23/2006 | WO2004108939A3 BAV packaging regions and E1 transcriptional control regions |
| 03/23/2006 | WO2004073659A3 HIV gp120 MIMOTOPE ANTIGEN |
| 03/23/2006 | WO2003083085A3 Transporters and ion channels |
| 03/23/2006 | US20060063922 Epidermal differentiation factor |
| 03/23/2006 | US20060063921 Ligand |
| 03/23/2006 | US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/23/2006 | US20060063697 Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses |
| 03/23/2006 | US20060063254 Antibody composition-producing cell |
| 03/23/2006 | US20060063250 Use of modified novirhabdoviruses to obtain vaccines |
| 03/23/2006 | US20060063230 Sulfatases and methods of use thereof |
| 03/23/2006 | US20060063228 Antibodies against human interleukin-13 and uses therefor |
| 03/23/2006 | US20060063212 Method of cancer screening; method of cancer treatment; and method of diabetes treatment |
| 03/23/2006 | US20060063200 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/23/2006 | US20060063167 DNA and proteins or peptides specific of the Neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 03/23/2006 | US20060062808 Inactivation of smooth muscle tissue |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062806 Flavivirus variants having phenotypic variation and immunogenic compositions thereof |
| 03/23/2006 | US20060062805 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 03/23/2006 | US20060062804 High sensitivity and specificity of the serologic detection; rapid, simple, low cost test for commercially available, large scale screening of SARS patients |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062801 Immunogens; electrical injection; electroporation |
| 03/23/2006 | US20060062800 Immunogens; envelope proteins; kits |
| 03/23/2006 | US20060062799 Sperm specific lysozyme-like proteins |
| 03/23/2006 | US20060062798 Vaccines |
| 03/23/2006 | US20060062797 Novel materials and methods for the treatment of Alzheimer's disease patients |
| 03/23/2006 | US20060062796 Polysaccharide-polypeptide conjugate |
| 03/23/2006 | US20060062795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 03/23/2006 | US20060062794 Composition containing particle surface charge control agent, particle separating method using same, particle separator |
| 03/23/2006 | US20060062793 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/23/2006 | US20060062792 Novel human p53 splice variant displaying differential transcriptional activity |
| 03/23/2006 | US20060062791 I kappa B kinase complex as a target for the treatment of Huntington's disease |
| 03/23/2006 | US20060062790 AKT3 inhibitors |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062788 Method for determining MIF content |
| 03/23/2006 | US20060062787 Method for treating Sjogren's syndrome |
| 03/23/2006 | US20060062786 Antibodies that immunospecifically bind to TRAIL receptors |
| 03/23/2006 | US20060062785 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia |
| 03/23/2006 | US20060062784 Compositions monovalent for CD40L binding and methods of use |
| 03/23/2006 | US20060062783 Monoclonal antibodies; immunoglobulins; glandular disorders |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062781 Specific ab1'-antibodies against tumour-associated antigen ca 125 |